Improving the understanding of originator and biosimilar biologics among healthcare providers in Saudi Arabia

Improving the understanding of originator and biosimilar biologics among healthcare providers in Saudi Arabia

The loss of patentability of many originator biologics has led to the rapid introduction of biosimilar agents. The anticipated economic benefit of introducing such agent has been accompanied by vagueness surrounding their biotechnology, approval requirements, positioning in treatment paradigms and p...

Full description

Bibliographic Details
Main Authors: Mohammed A. Omair, Tariq Alhawassi, Munira Alwaihibi, Ghada Aldrees, Mahmoud Mosli, Wesam M. Asser, Maryam A. Alharaibi, Atheer T. Alotaibi, Doaa A. Bintaleb, Najah K. Alharbi, Ahmed Z. Alotaibi, Wajed A. Alshammari, Nouf Alanazi, Ali M. Asiri, Rana Almadany, Hanan Al Rayes, Turki Al-Thunian, Moureq Alotaibi, Abdulrazaq Al Jazaeri
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:Saudi Pharmaceutical Journal
Online Access:http://www.sciencedirect.com/science/article/pii/S1319016420302693

Internet

http://www.sciencedirect.com/science/article/pii/S1319016420302693

Similar Items